REGENXBIO, Inc. (RGNX)
8.08
+0.14
(+1.76%)
USD |
NASDAQ |
Feb 24, 16:00
8.085
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Shareholders Equity (Annual) : 259.65M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 1.528B |
| Omeros Corp. | -182.61M |
| AbbVie, Inc. | -3.27B |
| CytomX Therapeutics, Inc. | -0.456M |
| Krystal Biotech, Inc. | 1.220B |